Is Plasma Renin Activity a Biomarker for the Prediction of Renal and Cardiovascular Outcomes in Treated Hypertensive Patients? Observations From the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

Study Questions:

What is the relationship between cardiovascular (CV) and renal outcomes and all-cause mortality with baseline measurements of plasma renin activity (PRA) among hypertensive adults randomized in the ASCOT trial?